- Major current issue is that US Vaccine rollout has taken 100% of focus of big hospitals. So CSX isn't sitting in front of key decision makers.
- Stock was trading on very optimistic expectations when it was near highs over $7
The valuation has gone from being excessive, to quite reasonable, as investors reset expectations.
Management made remarks that they expect the US hospitals to begin allocating resources to other areas once they get close to the 65-75% immunisation levels.
- Major current issue is that US Vaccine rollout has taken 100%...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
